Medicine & Health

A study in Nature led by Weikai Li at WashU Medicine reveals the molecular details of how vitamin K-dependent gamma carboxylase operates, a critical step in the blood clotting process.

Researchers at WashU Medicine led a study that offers a promising new way to reverse opioid overdoses without withdrawal symptoms.

Robi Mitra at WashU Medicine has received the Chancellor’s Award for Innovation and Entrepreneurship. In addition, in 2024 WashU jumped 11 places to No. 26 on the National Academy of Inventors list of the top 100 U.S. universities granted U.S. utility patents.

Barbara W. Trautner, MD, PhD, an internationally recognized physician-scientist, has been named the new co-director of the Division of Infectious Diseases in the Department of Medicine at WashU Medicine.

As the Oklahoma Legislature clears the way for autonomous practice by nurse practitioners, it’s time for a broader conversation regarding the scope and duration of training and certification needed to independently provide care to patients of all types, says Patrick Aguilar, MD, a business of health expert at WashU Olin Business School.

SPIE, the international society for optics and photonics, has awarded the prestigious SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics to Morgan Fogarty, a graduate student at WashU Medicine.

Researchers at WashU will study ways to fix malfunctioning ion channels responsible for neurological and heart illness.

WashU Medicine’s Invasive Fungal Infections Clinic has been named a Center of Excellence, Diamond Level, by the European Confederation of Medical Mycology in recognition of its three-fold excellence in diagnosis, management and research on fungal infections. It is one of two clinics with such status in the U.S. and one of 13 in the world.

Susan K. Dutcher, a professor of genetics and of cell biology and physiology at WashU Medicine, was elected to the National Academy of Sciences in recognition of her distinguished and continuing achievements in original research.

A small clinical trial, led by researchers at WashU Medicine, has found that moxidectin, a new medicine for river blindness, also works for lymphatic filariasis, another tropical disease.